XXVI World Congress of Neurology (WCN 2025)
From October 12 to 15, 2025, the XXVI World Congress of Neurology (WCN 2025) was held in Seoul, Republic of Korea-a dynamic metropolis rich in cultural heritage. The event was organized by the World Federation of Neurology (WFN) with the support of the Korean Neurological Association (KNA). The congress brought together neurologists, scientific researchers, and healthcare professionals from around the world, drawing attention to a unique and comprehensive scientific program.
The main objective of the forum was to promote educational processes and international knowledge exchange. The program included expert lectures, thematic scientific sessions, and the “Tournament of Minds” — an intellectual competition among teams of young specialists from various countries. Within the framework of the congress, training courses aimed at enhancing clinical competencies were conducted, as well as presidential and regional symposia showcasing the latest research findings and technological innovations in neurology. In addition, special attention was given to “Meet the Professor” sessions, interactive seminars, and professional debates on current issues in modern neurology.
The only delegates from Kazakhstan were Professor G.A. Mukhambetova from the Department of Nervous Diseases at Kazakh National Medical University and clinical supervisor of the department, chief freelance neurologist of the Almaty Health Department, S.M. Sarzhanova, who shared relevant issues, achievements, and prospects of Kazakhstan’s neurological service with their colleagues.
During the congress, participants were given the opportunity not only to deepen their practical skills and critically reassess modern approaches in neurology but also to establish professional contacts with foreign colleagues and leading experts. A central focus was the application of artificial intelligence in neurology-from fundamental research to clinical practice. Prospects for transforming neurological care through AI were discussed, including the development of personalized medicine, improving diagnostic accuracy, enhancing prognostic models, and optimizing therapeutic strategies for various neurological disorders. Updated clinical guidelines were reviewed, particularly regarding the management of patients with myasthenia, including modern methods of diagnosis and treatment. New data and clinical approaches aimed at improving treatment efficacy and patients’ quality of life were presented.
Holding the congress in the culturally rich atmosphere of Seoul, a city that harmoniously combines tradition and modern innovation, contributed not only to achieving high scientific goals but also provided participants with a significant cultural experience.
